LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

A Co-Inhibitory Alliance in Myeloid Leukemia: TIM-3/Galectin-9 Complex as a New Target for Checkpoint Blockade Therapy

Photo by nci from unsplash

Article history: Received 3 August 2017 Accepted 3 August 2017 Available online 4 August 2017 tion (Ozkazanc et al., 2016). Of note, under the control of these multiple inhibitory receptors,… Click to show full abstract

Article history: Received 3 August 2017 Accepted 3 August 2017 Available online 4 August 2017 tion (Ozkazanc et al., 2016). Of note, under the control of these multiple inhibitory receptors, the effector T cells easily become exhausted and anti-tumor immunity is diminished. Moreover, modulation of costimulatory molecules has been shown to substantially contribute to evasion from NK cell-mediated anti-leukemia immunity. The presence of PD-1 and TIM-3 indicates a fully responsive activated phenotype in NK cells

Keywords: inhibitory alliance; myeloid leukemia; alliance myeloid; august 2017; leukemia; tim

Journal Title: EBioMedicine
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.